Bietti’s Crystalline Dystrophy is a rare, slowly advancing retinal condition named for a distinctive feature seen on eye examination: small, glistening yellow-white crystalline deposits scattered across the retina. It has been reported more frequently in East Asian populations but occurs worldwide, and Ghanaian patients referred with this diagnosis are usually identified after a local ophthalmologist notices the characteristic crystalline appearance during a routine fundus exam.
Because the crystals themselves are a visible marker rather than the direct cause of vision loss, evaluation focuses on how much of the surrounding retinal tissue has already been affected by the underlying degenerative process, since that is what ultimately determines visual function.

Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience

Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience

Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
Because progression is typically slow, care planning for Bietti’s Crystalline Dystrophy centres on regular monitoring to track the rate of change, with regenerative stem cell therapy considered for eligible patients as a supportive measure aimed at preserving whatever retinal tissue remains functionally intact.
“The crystals function more as a diagnostic marker than a direct threat — it’s the accompanying thinning of the retina and choroid around them that drives the actual decline in vision, and that’s what evaluation and monitoring focus on.”
”
It tends to advance slowly, often over many years to decades, though the pace varies between individuals. This is part of why periodic monitoring, rather than a single evaluation, is generally recommended.”
“It has been reported more frequently in East Asian populations in published literature, though it isn’t confined to any single ethnicity and does turn up elsewhere, including in patients of Ghanaian and broader West African background.”
“The presence of the distinctive crystalline deposits on fundus examination, combined with confirmation of a CYP4V2 mutation on genetic testing, is what sets Bietti’s Crystalline Dystrophy apart from other rod-cone dystrophies that can otherwise look similar in their symptom pattern.”
